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Retroviruses require a balance of spliced and unspliced RNA for efficient replication. Here, we examined the effect of
mutations in a splicing suppressor sequence called the negative regulator of splicing (NRS), located within the gag gene of
Rous sarcoma virus. While the NRS mutant viruses showed only small changes in the levels of spliced env mRNAs, they had
significant increases in srcmRNA levels and transformed cells more efficiently than wild-type virus. None of these mutations
prevented viral replication; however, some of the mutant viruses replicated more slowly than wild-type virus. In addition,
increased transcriptional readthrough of the poly(A) site in the 3 LTR was observed with the NRS mutant viruses, suggesting
that the wild-type NRS sequence promotes polyadenylation. © 2002 Elsevier Science (USA)INTRODUCTION
Splicing of retroviral RNA transcripts differs from typi-
cal cellular mRNA splicing in several ways. Whereas
cellular pre-mRNAs are spliced to completion, viral splic-
ing is inefficient and the major viral mRNA species is
unspliced. Moreover, the primary retroviral transcript is
polycistronic and alternatively spliced to generate
mRNAs expressing different gene products. Cellular pre-
mRNA splicing, polyadenylation, and mRNA export are
all coupled (Niwa et al., 1990; Cooke et al., 1999; Luo and
Reed, 1999). In contrast, full-length viral RNAs are
capped, polyadenylated, and transported to the cyto-
plasm without being spliced (Coffin et al., 1997).
Like all retroviruses, Rous sarcoma virus (RSV) re-
quires unspliced RNA in the cytoplasm, where it func-
tions in a dual role as mRNA for gag–pol translation and
as packaged genomic RNA (Coffin et al., 1997). In addi-
tion, some full-length transcripts are alternatively spliced
to produce mRNAs for env and src gene products. Splic-
ing occurs from the single 5 splice site in gag to either
the env or the src 3 splice site. The maintenance of both
unspliced and spliced viral mRNAs is essential for viral
replication. Mutations that improve either of the subop-
timal 3 splice sites can cause an oversplicing pheno-
type that inhibits viral replication (Katz et al., 1988; Zhang
and Stoltzfus, 1995).
Since retroviruses depend on the cellular machinery
1 To whom correspondence and reprint requests should be addressed405for RNA transcription, processing, and export, they have
evolved mechanisms to aid in the accumulation of un-
spliced RNA. Complex retroviruses, such as HIV-1 and
HTLV-1, encode accessory proteins, Rev and Rex, which
promote export of incompletely spliced RNAs (reviewed
in Hope, 1999; Coffin et al., 1997). Simple retroviruses like
RSV have not been found to encode regulatory proteins
(Carlberg and Beemon, 1988; Coffin et al., 1997), suggest-
ing that they may use cis-acting RNA sequences to
interact with cellular factors. Both simian and avian ret-
roviruses have constitutive transport elements (CTE) that
promote export of unspliced RNA (Bray et al., 1994; Ogert
et al., 1996). To aid in the regulation of alternative splic-
ing, retroviruses contain strong 5 splice sites and weak
3 splice sites (Coffin et al., 1997; O’Reilly et al., 1995). In
addition, avian retroviruses have a cis-acting negative
regulator of splicing (NRS) element within the gag gene
(Fig. 1A) (Arrigo and Beemon, 1988). Both the suboptimal
3 splice sites and the NRS have been proposed to
contribute to the maintenance of unspliced RNA (Mc-
Nally and Beemon, 1992).
The NRS is a 230-nucleotide (nt) RNA sequence, which
is conserved among avian retroviruses (McNally et al.,
1991). It inhibits splicing in heterologous constructs
when located within approximately 300 nt of a 5 splice
site, a position similar to its location in the viral genome
(Arrigo and Beemon, 1988; McNally et al., 1991). The NRS
has two functional domains: an SR and hnRNP H protein-
binding domain in its purine-rich 5 portion (McNally and
McNally, 1996; Fogel and McNally, 2000) and overlappingKey Words: Rous sarcoma virus; mRNA splicing; polyad
RNA.
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U1 and U11 snRNP binding sites at its 3 end (Hibbert et
al., 1999; McNally and McNally, 1999). Mutations that
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improve the major 5 splice site consensus in the NRS
activate splicing from this site in a heterologous con-
struct (Paca et al., 2001). Changes that weaken this
consensus inactivate the NRS (Hibbert et al., 1999; Mc-
Nally and McNally, 1999). A point mutation at 5 in the
major 5 splice site-like sequence inactivates the NRS
and can be partially rescued by a compensatory muta-
tion in U1 snRNA (Hibbert et al., 1999). However, muta-
tions in the minor 5 splice site sequence were not
complemented by compensatory changes in U11 snRNA
(C. Hibbert and K. Beemon, unpublished data). These
observations suggest that some other factor could be
interacting with this region of the NRS. We recently sug-
gested that sequences in the 3 end of the NRS (RSV nt
916–928) may also form a stable interaction with U6
snRNA (Paca et al., 2001).
The NRS has been proposed to act as a decoy 5
splice site, which generates a nonproductively spliced
complex with a downstream 3 splice site (Gontarek,
1994; Cook and McNally, 1999). It has also been sug-
gested that the NRS may promote polyadenylation; large
(606 nt) gag deletions, which include the NRS and flank-
ing sequences, lead to increased readthrough of the 3
poly(A) site (Miller and Stoltzfus, 1992).
In this report, we examined the effect of several point
mutations in the NRS on viral RNA splicing and
readthrough transcription in cultured cells. These muta-
tions were generated in full-length, replication-compe-
tent viral constructs and were designed to maintain the
wild-type Gag amino acid sequence. Analysis of viral
RNA products revealed changes in the accumulation of
spliced messages. Splicing to the proximal env 3 splice
site was not greatly altered, but increased splicing to the
distal src 3 splice site was observed with all of the NRS
mutants. This suggests that the NRS does not inhibit
splicing uniformly but rather selectively inhibits splicing
to the distal src 3 splice site. Accordingly, most of the
mutant viruses transformed chicken embryo fibroblasts
(CEFs) more efficiently than wild-type virus. While some
of the mutations delayed viral replication, none of them
prevented viral replication. Finally, the NRS mutants ex-
hibited increased readthrough of the viral 3 poly(A) site,
confirming a role for the NRS in the promotion of poly-
adenylation.
RESULTS
Generation of NRS point mutations in full-length viral
constructs
The current study investigates the effects of NRS point
mutations on RNA splicing and polyadenylation in full-
length viral constructs. The 3 terminus of the NRS con-
tains binding sites for U1 and U11 snRNPs (Fig. 1A).
(Gontarek et al., 1993; Hibbert et al., 1999; McNally and
McNally, 1999). An alignment of major (U1-binding) and
minor (U11-binding) 5 splice site consensus sequences
with the NRS 3 terminal sequence is shown in Fig. 1B.
Four NRS mutants were generated in this region; none of
the mutations altered the Gag amino acid sequence (Fig.
1B). Mutant U916A changed the major 5 splice site-like
sequence at position 2 from the canonical U to an A.
Mutant G919A contains a single point mutation that af-
fects both the major (position 5), and the minor (posi-
tion1) 5 splice site consensus sequences. Mutant 925
altered 3 consecutive nt (925–927) from UUC to AAG,
disrupting the minor 5 splice site and also the proposed
secondary structure of the NRS. The fourth mutant,
termed NRS.1, contained 3 nt substitutions: U917C,
G919U, and U922C, affecting both 5 splice site se-
quences. All four of these mutants also change the NRS
sequence proposed to base-pair with U6 snRNA (Fig. 1B)
(Paca et al., 2001). When inserted into the cellular myc
intron and transfected into CEFs, all of these mutants
were found to inactivate the splicing suppression of the
NRS (data not shown).
NRS mutants preferentially increase src mRNA levels
The contribution of the NRS to differential retroviral
splicing has not previously been studied in replication-
competent viruses. Previous analyses of viral constructs
with NRS deletions showed increases in total spliced
RNA (Arrigo and Beemon, 1988). In the Prague A(Pr-A)
RSV, large gag deletions that include the NRS lead to an
FIG. 1. Generation of NRS mutations in full-length PrC RSV constructs.
(A) Probes used to distinguish the different mRNA species are shown
below the full-length RNA transcript. The probes are complementary to the
5 splice site and to the env and src 3 splice sites. The NRS, located within
the gag gene, binds SR proteins, including ASF/SF2 in its 5 domain and
U1 and U11 snRNPs at its 3 end. (B) Mutations that do not alter the Gag
amino acid sequence were generated in the 3 end of the NRS (RSV nt
911–928 are shown.) Overlapping major (U1 binding) and minor (U11
binding) consensus 5 splice site sequences are indicated. The NRS is
also complementary to U6 snRNA nts 33 to 45.
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increased accumulation of both env and src spliced
mRNAs (Stoltzfus and Fogarty, 1989). To analyze the
effects of NRS mutations on splicing of viral RNA, full-
length viral constructs containing the NRS point muta-
tions described above (Fig. 1B) were transfected into
CEFS, and virus was allowed to replicate for 6 days. At
this time, total cellular RNA was harvested and RNase
protection assays were performed. Three different
probes spanning the viral 5 and both 3 splice sites
were used, as shown in Fig. 1A.
Total viral splicing, measured as the percentage of
RNA spliced from the viral splice donor site at nt 397, was
variably affected by these mutations. However, the
changes in amount of total spliced mRNAs were rela-
tively small with these full-length viral constructs (Fig.
2A). Using the splice donor probe, wild-type spliced RNA
represented 9% of the total RNA. Mutants 919 and 925
showed small increases in total spliced RNA to 12 and
14%, respectively. Mutant NRS.1 exhibited 17% spliced
RNA, which is about twice as much as the wild-type
construct. Surprisingly, mutant 916 did not show an in-
crease in splicing; in fact, splicing was decreased to 7%
of the total RNA (Fig. 2A).
Using a probe spanning the env splice acceptor site,
the effect of the NRS mutations on env mRNA levels was
determined. Changes in the relative amounts of env
mRNA were small with all of the mutants (Fig. 2B). Both
NRS 916 and 919 mutants exhibited less env mRNA
splicing (approximately 10%) than wild type (15%) with
this probe. Only the 925 triple mutant had an increase in
env mRNA levels to about 19% spliced RNA. The NRS.1
mutant had levels of env mRNA (14%) very similar to
those of wild-type virus.
In contrast to env mRNA splicing, levels of src mRNA
were significantly changed with these NRS mutants. The
amount of src mRNA relative to unspliced RNA increased
as much as fourfold over wild-type levels in these experi-
ments (Fig. 2C). While the wild-type virus exhibited only
about 3% src mRNA, this increased to approximately 13%
with the NRS.1 construct. The 916, 919, and 925 mutants
showed 4, 9, and 6% src mRNA, respectively. Thus, it ap-
peared that the NRS mutations relieved the suppression of
splicing at the distal src 3 splice site more efficiently than
at the proximal env 3 splice site. Consequently, while the
wild-type PrC RSV exhibited about fivefold more env than
src mRNA, some of these mutant viruses accumulated
more similar amounts of env and src mRNAs.
In summary, differential effects on splicing were ob-
served with the NRS mutants. Mutant 916 showed the
smallest effects on src, env, and total mRNA splicing.
Mutants NRS.1 and 919 showed the largest amounts of
src mRNA. Mutant 925 was the only mutant that in-
creased env mRNA levels slightly, while also increasing
src mRNA (Fig. 2). None of these mutants had large
effects on levels of unspliced RNA, which varied from the
wild-type level of about 90% to about 83% with NRS.1.
NRS inactivation is associated with a more rapid
transformation phenotype
The increase in src mRNA levels, depicted in Fig. 2C,
led us to investigate the transforming capacity of the
NRS mutant viruses. At 6 days posttransfection, the wild-
type RSV and mutant 916-infected cells were only slightly
transformed morphologically (Fig. 3). However, all of the
other mutant virus-infected cells displayed higher de-
grees of transformation than cells infected with the wild-
type virus. The mutant transformed cultures appeared
more refractile, less adherent, and not subject to contact
inhibition of growth (Fig. 3). The extent of transformation
correlated well with the amount of src mRNA assayed by
RNase protection (Fig. 2C), in that the wild-type and the
916 mutant virus had significantly less srcmRNA than the
919, 925, and NRS.1 mutants. These data suggested that
FIG. 2. NRS point mutations alter the accumulation of viral mRNAs.
Wild-type RSV and mutants described in Fig. 1B were transfected into
CEFs. After 6 days, total cellular RNA was harvested and subjected to
RNase protection assays with probes that span (A) the viral 5 splice
site in the gag gene, (B) the env 3 splice site, and (C) the src 3 splice
site. Error bars represent the standard deviation from the mean for at
least three independent transfection experiments. Raw results in the
left column are replotted on the right to show the alteration in RNA
accumulation relative to the WT levels, which were normalized to one.
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cellular transformation resulting from RSV infection may
occur when a threshold level of src mRNA is exceeded.
The correlation between the increase in src mRNA
levels and that in the rate of transformation by the NRS
mutant viruses suggested that an increase in the RSV
Src kinase activity was likely responsible. To determine
whether the src mRNAs we detected by RNase protec-
tion were functional, we measured Src kinase activity in
immunoprecipitates from infected cells as described
previously (Beemon, 1981). Src kinase activity correlated
well with src mRNA levels (data not shown), suggesting
that the src mRNAs are functional.
NRS splicing inhibition is not required for viral
replication
Previous studies of RSV splicing regulation have shown
that both src and env 3 splice sites need to be suboptimal
for efficient viral replication. If efficient splicing occurs due
to mutations improving either of the 3 splice sites, viral
replication is severely impaired (Katz and Skalka, 1990;
Zhang and Stoltzfus, 1995). Here we investigated whether
point mutations in the NRS which increased splicing of src
mRNA would impair viral replication.
To assay viral replication, the viral constructs de-
scribed above (Fig. 1B) were transfected into CEFs. Vi-
rus-containing media were harvested at 24-h intervals,
and reverse transcriptase activity in the media was as-
sayed to determine virus production. This experiment
was repeated four times, and a typical experiment is
shown in Fig. 4. While the previously reported delayed
growth phenotype was reproducibly noted for the NRS.1
mutant (Hibbert et al., 1999), the other mutations had
smaller and more variable effects, slowing viral replica-
tion only slightly with respect to wild-type RSV (Fig. 4).
This is not surprising since the unspliced and spliced
env mRNAs needed for virion protein production were
not greatly affected by these mutations (Fig. 2). The
NRS.1 mutant may have a greater effect on viral replica-
tion because its three point mutations are dispersed over
a 6-nt region and may affect binding of multiple factors.
This mutant also caused the largest increase in src
mRNA and total spliced RNA, thus diminishing the un-
spliced RNA population the most. Thus, it appears that
the wild-type NRS sequence is not essential for viral
replication, but it appeared to give the virus a slight
growth advantage in cultured CEF cells.
NRS mutants have increased readthrough of the
poly(A) site in the 3 LTR
Earlier work of Miller and Stoltzfus (1992) showed that
large (606 nt) gag deletions that remove the NRS and
flanking sequences lead to a substantial readthrough of
the poly(A) site. This poly(A)-promoting sequence in gag
FIG. 3. NRS mutants induce a more rapid transformation phenotype. Photomicrographs of CEFs were taken 6 days after transfection with the
various viral constructs.
FIG. 4. The NRS is not essential for viral replication. Viral replication
rates were measured by reverse transcriptase assays of virus in the
culture media. Assays were carried out at 24-h time intervals after
transfection of CEFs with the viral constructs.
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is orientation-dependent (Miller and Stoltzfus, 1992) as is
the NRS (Arrigo and Beemon, 1988; McNally et al., 1991).
Wild-type RSV and avian leukosis viruses (ALVs) typically
exhibit about 15% readthrough of the poly(A) site (Her-
man and Coffin, 1986), but the deleted constructs show
approximately 50% readthrough levels (Miller and Stoltz-
fus, 1992). This observation led us to investigate whether
the NRS point mutations in this study lead to an increase
in readthrough transcription.
Readthrough transcription was detected by an RNase
protection assay, using a readthrough probe, as shown in
Fig. 5A. Readthrough RNA was quantified and compared to
the amount of RNA polyadenylated at the normal viral 3
poly(A) site, and the results are shown in Fig. 5B. The
wild-type RSV readthrough observed was 14%, which is
similar to the 15% levels observed earlier with other viral
strains (Herman and Coffin, 1986; Miller and Stoltzfus,
1992). Mutant 916 showed a similar readthrough level of
15%; this mutant also showed splicing and transformation
phenotypes very similar to those of the wild-type virus.
However, mutants 919, 925, and NRS.1 had increased
readthrough transcription (22, 18, and 23%, respectively),
mirroring their increases in srcmRNA levels (Fig. 2C). Thus,
the mutants with the largest increases in splicing to src
also had the most readthrough of the poly(A) site. In con-
clusion, the NRSmutants were found to have an increase in
readthrough levels, suggesting that the wild-type NRS plays
a role in promoting polyadenylation within the 3 LTR.
DISCUSSION
A series of point mutations in the RSV NRS element
were generated in full-length viral constructs, and the
effects of these mutations on viral mRNA splicing, cell
transformation, replication, and polyadenylation were as-
sayed. Analysis of viral RNA species indicated that some
of these mutations caused a significant increase in the
relative amount of src mRNA but had a smaller effect
(often a decrease) on the ratio of env mRNA to unspliced
RNA. While none of the mutations blocked viral growth in
culture, most of the mutant viruses transformed CEFs
more rapidly than wild-type virus. In addition, the mutants
exhibited increased transcriptional readthrough of the 3
poly(A) site.
FIG. 5. NRS mutants show increased readthrough of the 3 poly(A) site. (A) The readthrough probe spans the LTR and includes part of the 3
untranslated region (UTR) and the 5 UTR region. Normally polyadenylated RNA hybridizes to the 3 UTR, U3, and R regions of the probe. However,
a readthrough RNA also hybridizes to the U5 region, generating a larger protected fragment. (B) Total RNA was harvested from CEFs 6 days
posttransfection with viral constructs and subjected to RNase protection assays with the probe described above.
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The selective suppression of src mRNA splicing
In contrast to previous results with large deletion mu-
tants in PrA RSV (Stoltzfus and Fogarty, 1989), our Prague
C (PrC) NRS point mutations did not greatly influence the
relative levels of env mRNA, and therefore did not
change the balance of unspliced and spliced viral RNAs
needed for viral replication. Thus, it appears that the use
of a suboptimal env 3 splice site is the primary mecha-
nism used to maintain balanced splicing of PrC RSV
RNA. The env 3 splice site has a poor branch-point
sequence (Fu et al., 1991); insertions that provide a better
branch-point sequence cause an oversplicing phenotype
that blocks viral replication (Katz et al., 1988; Katz and
Skalka, 1990).
In RSV, the src 3 splice site is also inefficient. It has a
weak polyprimidine tract and an upstream suppressor el-
ement, termed the Suppressor of Src Splicing (Berberich
and Stoltzfus, 1991a). Nevertheless, we observed up to four-
to fivefold increases in splicing to srcwith some of our NRS
mutants, in some cases raising srcmRNA levels to those of
env. The increases, however, did not substantially reduce
the large pool of unspliced RNA, representing approxi-
mately 90% of the total RNA of wild-type PrC RSV. This may
explain why these mutants did not greatly affect viral rep-
lication. In contrast, 3 splice site mutants, which enhanced
splicing and blocked viral growth, diminished unspliced
RNA levels substantially (Zhang and Stoltzfus, 1995; Katz
and Skalka, 1990).
If the effects of the NRS on splicing were mediated by a
simple 5 splice site competition model, then mutations of
the NRS would be expected to affect both the env and the
src 3 splice sites equally. In contrast, the selective inhibi-
tion of splicing to src we observed suggests that the env
and src 3 splice sites interact differently with the NRS.
Splice site mutagenesis studies of Stoltzfus and co-workers
also suggest that env splicing is regulated independently of
src splicing (Berberich and Stoltzfus, 1991b).
NRS promotes polyadenylation
Mutant viruses that generated increased src mRNA
also exhibited increased readthrough of the 3 poly(A)
site. This suggests that an additional function of the NRS
is to promote polyadenylation, as previously proposed by
Miller and Stoltzfus (1992) based on large deletion mu-
tants that showed about a threefold increase in polyad-
enylation. Our results with the NRS point mutations were
smaller in magnitude, with a maximum of about a 50%
increase in readthrough. Perhaps other regulatory se-
quences in the 606-nt region deleted also affect polyad-
enylation.
In spliced cellular mRNAs, the terminal 3 splice site
promotes polyadenylation (Niwa et al., 1990). In contrast,
in unspliced cellular RNAs the 5 cap can promote poly-
adenylation (Cooke et al., 1999). In unspliced RSV RNA,
the interaction between the NRS and weak 3 splice sites
may facilitate polyadenylation. This could occur either
directly, by recruiting polyadenylation factors as pro-
posed by Miller and Stoltzfus (1992), or indirectly, per-
haps through promotion of the interaction between the
cap and the polyadenylation machinery. Readthrough of
the poly(A) site is a likely precursor to the generation of
transducing viruses, including RSV (Coffin et al., 1997).
Does the NRS modulate tumorigenesis?
While the NRS is clearly a splicing control element, its
role in splicing suppression is not as direct as previously
thought. In the full-length viral context, the NRS appears
to suppress the distal src 3 splice site selectively over
the proximal env 3 splice site. Our data suggest that the
level of src mRNA at early times after infection with
wild-type PrC RSV may be insufficient to promote trans-
formation in most cells and that the enhanced splicing to
src seen with the NRS mutants may promote earlier
transformation. Similarly, when an inducible promoter
controls v-src expression, a fourfold increase in expres-
sion can induce transformation (Jakobovits et al., 1984).
Additionally, Src may up-regulate its own expression in
RSV-transformed cells through enhanced splicing to the
src 3 splice site (Csepany et al., 1990). Furthermore, src
overexpression can lead to enhanced transcription,
splicing changes, and transport of partially spliced cel-
lular RNAs (Neel et al., 1995).
We have demonstrated that the PrC RSV NRS se-
quence preferentially suppresses splicing of src mRNA.
However, it seems unlikely that the NRS evolved in RSV
to regulate splicing of src. In the ALV, the progenitor of
RSV, the NRS may have evolved to suppress readthrough
and splicing from ALVs to downstream cellular genes.
Rapid-onset lymphomas are induced by an ALV which
integrates upstream of the cellular myb gene and splices
an ALV-myb readthrough RNA to generate a truncated
Myb protein (Jiang et al., 1997). A 42-nt deletion in the
NRS element, which partially inactivates the NRS,
strongly promotes this tumorigenesis, suggesting that
enhanced splicing to downstream sequences contrib-
utes to the oncogenic process (Smith et al., 1997). As the
NRS appears to inhibit splicing to cellular 3 splice sites
more efficiently than to env, its role in the viral life cycle
may be to limit splicing to downstream cellular exons
that have been transcribed by readthrough of the viral
polyadenylation site. Unchecked readthrough, which is
also regulated by the NRS, is likely to increase the
incidence of tumorigenesis when the virus integrates
upstream of a proto-oncogene. The NRS deletion in
ALVs, like the NRS point mutations characterized here,
may contribute to rapid lymphomagenesis by promoting
readthrough, as well as splicing, to downstream cellular
genes.
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MATERIALS AND METHODS
DNA constructs
NRS point mutations were generated in viral con-
structs containing the full-length, replication-competent
genome of the PrC strain of RSV (Barker and Beemon,
1991). First, the SacII fragment (nt 543–1806) of the plas-
mid pPrC was inserted into pBluescript KS (Strat-
agene). The mutations shown in Fig. 1B were generated
in this subclone with the Quick-Change mutagenesis kit
(Stratagene). SacII fragments containing NRS mutations
were then ligated back into the full-length pPrC plasmid.
The mutations were confirmed by sequencing.
Cell culture and DNA transfection
Primary CEFs were prepared according to Rein and
Rubin (1968) and maintained in Medium 199 containing
2% tryptose phosphate broth, 1% calf serum, 1% heat-
treated chick serum, and 1% antibiotic–antimycotic (Life
Technologies, Inc.). CEFs on 10-cm plates were trans-
fected with 5–7 g plasmid DNA in serum-free Medium
199 containing 200 g/ml DEAE-dextran. After 4 h, cells
were shocked for 2 min at room temperature in Medium
199 containing 10% dimethyl sulfoxide (Arrigo and Bee-
mon, 1998).
RNA isolation and analysis
RNA was isolated 6 days after transfection using RNa-
zol B (Tel-Test) and subjected to RNase protection as-
says. Total cellular RNA (1/50 of a 10-cm plate) was
hybridized to three different 32P-labeled probes at 55°C
for 16 h; the viral 5 splice site probe (Barker and Bee-
mon, 1991) and src and env 3 splice site probes
(Csepany et al., 1990) are shown in Fig. 1A. Digestions
with RNase T1 and RNase A were carried out at room
temperature as previously described (Barker and Bee-
mon, 1991). After gel electrophoresis, quantitation of pro-
tected RNAs was performed on an InstantImager (Pack-
ard), and molar ratios of spliced and unspliced RNAs
were determined.
Readthrough transcription was assayed with a ribo-
probe spanning the LTR, ranging from the 3 UTR (Bsu36I
site at nt 8884) to the 5 UTR (SacI site at nt 255), inserted
into pSL301 (Invitrogen). The plasmid was linearized with
BglII and transcribed with T3 RNA polymerase (New
England Biolabs). The probe was hybridized with total
cellular RNA at 55°C for 16 h and digested with RNase
T1 and RNase A at 37°C.
Reverse transcriptase assays
Viral growth was monitored by quantitating the reverse
transcriptase activity of virus shed into the cell culture
media, using the assay described by Telesnitsky et al.
(1995).
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